Genoma Research Group, Inc. is a clinical research site located in Miami, Florida, United States 33165.
Crixeo Health Trust Score: 76/100 (FAIR). This profile has not yet been claimed by the site owner.
Genoma Research Group, Inc. has participated in 10 clinical trials with 2 currently active.
Therapeutic areas: Type 2 Diabetes Mellitus With Diabetic Nephropathy, Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis.
Sponsors: Calliditas Therapeutics AB, Galectin Therapeutics Inc., Eli Lilly and Company.
Trust Score: 76/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
Genoma Research Group, Inc. has a Crixeo Trust Score of 76/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Genoma Research Group, Inc. has 10 clinical trials on record, with 2 currently active. Their work covers Type 2 Diabetes Mellitus With Diabetic Nephropathy, Prevention of Esophageal Varices, NASH - Nonalcoholic Steatohepatitis.
Yes — Genoma Research Group, Inc. holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.